| QC6 | Name: | 8-fluoro-2-methylquinolin-4-amine | Formula: | C10 H9 F N2 | SMILES: | Fc1cccc2c(N)cc(C)nc12 | InChi: | InChI=1S/C10H9FN2/c1-6-5-9(12)7-3-2-4-8(11)10(7)13-6/h2-5H,1H3,(H2,12,13) | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 8-fluoro-2-methylquinolin-4-amine |
|
| QCA | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H16 N4 O7 | SMILES: | NC(C(O)C)C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(N(=O)=O)c(cc2)O | InChi: | InChI=1S/C15H16N4O7/c1-7(20)13(16)14-17-9(15(24)18(14)6-12(22)23)4-8-2-3-11(21)10(5-8)19(25)26/h2-5,7,13,20-21H,6,16H2,1H3,(H,22,23)/b9-4-/t7-,13+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2019-10-11 | Last modified: | 2023-11-03 | Release date: | 2020-10-14 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-nitrophenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| QCC | Name: | 2-(3-chloro-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C17 H16 Cl N3 O3 | SMILES: | Cc1ccncc1NC(=O)Cc1cc(Cl)cc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C17H16ClN3O3/c1-10-2-3-19-9-14(10)20-15(22)6-11-4-12(18)7-13(5-11)24-17-8-16(23)21-17/h2-5,7,9,17H,6,8H2,1H3,(H,20,22)(H,21,23)/t17-/m0/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-{[(2S)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| QCD | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-methoxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl
}acetic acid | Formula: | C16 H19 N3 O6 | SMILES: | NC(C(O)C)C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(OC)c(cc2)O | InChi: | InChI=1S/C16H19N3O6/c1-8(20)14(17)15-18-10(16(24)19(15)7-13(22)23)5-9-3-4-11(21)12(6-9)25-2/h3-6,8,14,20-21H,7,17H2,1-2H3,(H,22,23)/b10-5-/t8-,14+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2019-10-11 | Last modified: | 2023-11-03 | Release date: | 2020-10-14 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-methoxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| QCI | Name: | L-2-Aminoglutarimide | Formula: | C5 H8 N2 O2 | SMILES: | N[CH]1CCC(=O)NC1=O | InChi: | InChI=1S/C5H8N2O2/c6-3-1-2-4(8)7-5(3)9/h3H,1-2,6H2,(H,7,8,9)/t3-/m0/s1 | Synonyms: | (3S)-3-azanylpiperidine-2,6-dione | Definition date: | 2022-10-25 | Last modified: | 2023-11-03 | Release date: | 2023-01-11 | Identifier: | (3~{S})-3-azanylpiperidine-2,6-dione |
|
| QCO | Name: | N-[(1R)-2-{[2-(3-fluorophenyl)ethyl]amino}-2-oxo-1-(pyridin-3-yl)ethyl]-N-{4-[(propan-2-yl)oxy]phenyl}-1H-imidazole-4-carboxamide | Formula: | C28 H28 F N5 O3 | SMILES: | O=C(N(C(c1cccnc1)C(=O)NCCc1cccc(F)c1)c1ccc(OC(C)C)cc1)c1c[NH]cn1 | InChi: | InChI=1S/C28H28FN5O3/c1-19(2)37-24-10-8-23(9-11-24)34(28(36)25-17-31-18-33-25)26(21-6-4-13-30-16-21)27(35)32-14-12-20-5-3-7-22(29)15-20/h3-11,13,15-19,26H,12,14H2,1-2H3,(H,31,33)(H,32,35)/t26-/m1/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[(1R)-2-{[2-(3-fluorophenyl)ethyl]amino}-2-oxo-1-(pyridin-3-yl)ethyl]-N-{4-[(propan-2-yl)oxy]phenyl}-1H-imidazole-4-carboxamide |
|
| QCS | Name: | S-carbamoyl-L-cysteine | Formula: | C4 H8 N2 O3 S | SMILES: | O=C(SCC(C(=O)O)N)N | InChi: | InChI=1S/C4H8N2O3S/c5-2(3(7)8)1-10-4(6)9/h2H,1,5H2,(H2,6,9)(H,7,8)/t2-/m0/s1 | Definition date: | 2013-10-21 | Last modified: | 2023-11-03 | Release date: | 2013-12-18 | Identifier: | S-carbamoyl-L-cysteine |
|
| C0F | Name: | (4~{R})-2-[4-[(2~{S})-2,3-bis(azanyl)-3-oxidanylidene-propyl]pyridin-2-yl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid | Formula: | C12 H14 N4 O3 S | SMILES: | N[CH](Cc1ccnc(c1)C2=N[CH](CS2)C(O)=O)C(N)=O | InChi: | InChI=1S/C12H14N4O3S/c13-7(10(14)17)3-6-1-2-15-8(4-6)11-16-9(5-20-11)12(18)19/h1-2,4,7,9H,3,5,13H2,(H2,14,17)(H,18,19)/t7-,9-/m0/s1 | Definition date: | 2019-04-03 | Last modified: | 2023-11-03 | Release date: | 2019-06-26 | Identifier: | (4~{R})-2-[4-[(2~{S})-2,3-bis(azanyl)-3-oxidanylidene-propyl]pyridin-2-yl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
|
| QD1 | Name: | 6-chloroquinolin-4-amine | Formula: | C9 H7 Cl N2 | SMILES: | Clc1ccc2nccc(N)c2c1 | InChi: | InChI=1S/C9H7ClN2/c10-6-1-2-9-7(5-6)8(11)3-4-12-9/h1-5H,(H2,11,12) | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 6-chloroquinolin-4-amine |
|
| QD4 | Name: | (4R)-6-chloro-N~4~-(isoquinolin-4-yl)-3,4-dihydroquinoline-1,4(2H)-dicarboxamide | Formula: | C20 H17 Cl N4 O2 | SMILES: | NC(=O)N1CCC(c2cc(Cl)ccc21)C(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C20H17ClN4O2/c21-13-5-6-18-16(9-13)15(7-8-25(18)20(22)27)19(26)24-17-11-23-10-12-3-1-2-4-14(12)17/h1-6,9-11,15H,7-8H2,(H2,22,27)(H,24,26)/t15-/m1/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N~4~-(isoquinolin-4-yl)-3,4-dihydroquinoline-1,4(2H)-dicarboxamide |
|
| C0O | Name: | (~{Z},2~{R},6~{S})-2,6-bis(azanyl)hept-3-enedioic acid | Formula: | C7 H12 N2 O4 | SMILES: | N[CH](CC=C[CH](N)C(O)=O)C(O)=O | InChi: | InChI=1S/C7H12N2O4/c8-4(6(10)11)2-1-3-5(9)7(12)13/h1-2,4-5H,3,8-9H2,(H,10,11)(H,12,13)/b2-1-/t4-,5+/m1/s1 | Definition date: | 2019-04-03 | Last modified: | 2023-11-03 | Release date: | 2020-01-15 | Identifier: | (~{Z},2~{R},6~{S})-2,6-bis(azanyl)hept-3-enedioic acid |
|
| QD9 | Name: | N-[(3-chlorophenyl)methyl]-N-[5-(dimethylamino)pyridin-2-yl]-2-(isoquinolin-4-yl)acetamide | Formula: | C25 H23 Cl N4 O | SMILES: | CN(C)c1cnc(cc1)N(Cc1cccc(Cl)c1)C(=O)Cc1cncc2ccccc21 | InChi: | InChI=1S/C25H23ClN4O/c1-29(2)22-10-11-24(28-16-22)30(17-18-6-5-8-21(26)12-18)25(31)13-20-15-27-14-19-7-3-4-9-23(19)20/h3-12,14-16H,13,17H2,1-2H3 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[(3-chlorophenyl)methyl]-N-[5-(dimethylamino)pyridin-2-yl]-2-(isoquinolin-4-yl)acetamide |
|
| QDF | Name: | (4R)-6-chloro-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide | Formula: | C19 H14 Cl N3 O2 | SMILES: | Clc1ccc2NC(=O)CC(c2c1)C(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C19H14ClN3O2/c20-12-5-6-16-14(7-12)15(8-18(24)22-16)19(25)23-17-10-21-9-11-3-1-2-4-13(11)17/h1-7,9-10,15H,8H2,(H,22,24)(H,23,25)/t15-/m1/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N-(isoquinolin-4-yl)-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxamide |
|
| QDI | Name: | 6-fluoroquinolin-4-amine | Formula: | C9 H7 F N2 | SMILES: | Fc1ccc2nccc(N)c2c1 | InChi: | InChI=1S/C9H7FN2/c10-6-1-2-9-7(5-6)8(11)3-4-12-9/h1-5H,(H2,11,12) | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 6-fluoroquinolin-4-amine |
|
| QDU | Name: | 2-(2,5-difluorophenyl)-N-(isoquinolin-4-yl)acetamide | Formula: | C17 H12 F2 N2 O | SMILES: | Fc1cc(CC(=O)Nc2cncc3ccccc32)c(F)cc1 | InChi: | InChI=1S/C17H12F2N2O/c18-13-5-6-15(19)12(7-13)8-17(22)21-16-10-20-9-11-3-1-2-4-14(11)16/h1-7,9-10H,8H2,(H,21,22) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(2,5-difluorophenyl)-N-(isoquinolin-4-yl)acetamide |
|
| C1J | Name: | N~5~-(N-octylcarbamimidoyl)-L-ornithine | Formula: | C14 H30 N4 O2 | SMILES: | NC(C(O)=O)CCCN/C(NCCCCCCCC)=N | InChi: | InChI=1S/C14H30N4O2/c1-2-3-4-5-6-7-10-17-14(16)18-11-8-9-12(15)13(19)20/h12H,2-11,15H2,1H3,(H,19,20)(H3,16,17,18)/t12-/m0/s1 | Definition date: | 2017-09-08 | Last modified: | 2023-11-03 | Release date: | 2017-12-13 | Identifier: | N~5~-(N-octylcarbamimidoyl)-L-ornithine |
|
| QE3 | Name: | 2-(5-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide | Formula: | C16 H12 Cl N3 O | SMILES: | O=C(Cc1ccc(Cl)cn1)Nc1cncc2ccccc21 | InChi: | InChI=1S/C16H12ClN3O/c17-12-5-6-13(19-9-12)7-16(21)20-15-10-18-8-11-3-1-2-4-14(11)15/h1-6,8-10H,7H2,(H,20,21) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(5-chloropyridin-2-yl)-N-(isoquinolin-4-yl)acetamide |
|
| QEF | Name: | 6-fluoro-2-methylquinolin-4-amine | Formula: | C10 H9 F N2 | SMILES: | Fc1ccc2nc(C)cc(N)c2c1 | InChi: | InChI=1S/C10H9FN2/c1-6-4-9(12)8-5-7(11)2-3-10(8)13-6/h2-5H,1H3,(H2,12,13) | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 6-fluoro-2-methylquinolin-4-amine |
|
| C1X | Name: | (Z)-N~6~-[(4R,5S)-5-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)DIHYDRO-2H-THIOPYRAN-3(4H)-YLIDENE]-L-LYSINE | Formula: | C16 H26 N2 O6 S | SMILES: | O=C(O)C(N)CCCC/N=C1/CSCC(CCC(=O)O)C1CC(=O)O | InChi: | InChI=1S/C16H26N2O6S/c17-12(16(23)24)3-1-2-6-18-13-9-25-8-10(4-5-14(19)20)11(13)7-15(21)22/h10-12H,1-9,17H2,(H,19,20)(H,21,22)(H,23,24)/b18-13-/t10-,11-,12+/m1/s1 | Synonyms: | 2-AMINO-6-[5-(2-CARBOXY-ETHYL)-4-CARBOXYMETHYL-DIHYDRO-THIOPYRAN-3-YLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2023-11-03 | Identifier: | (E)-N~6~-[(4R,5S)-5-(2-carboxyethyl)-4-(carboxymethyl)dihydro-2H-thiopyran-3(4H)-ylidene]-L-lysine |
|
| QER | Name: | 2-(3-fluorophenyl)-N-(isoquinolin-4-yl)acetamide | Formula: | C17 H13 F N2 O | SMILES: | Fc1cccc(c1)CC(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C17H13FN2O/c18-14-6-3-4-12(8-14)9-17(21)20-16-11-19-10-13-5-1-2-7-15(13)16/h1-8,10-11H,9H2,(H,20,21) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-fluorophenyl)-N-(isoquinolin-4-yl)acetamide |
|
| QEX | Name: | N-(isoquinolin-4-yl)-2-(3-methylphenyl)acetamide | Formula: | C18 H16 N2 O | SMILES: | Cc1cccc(c1)CC(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C18H16N2O/c1-13-5-4-6-14(9-13)10-18(21)20-17-12-19-11-15-7-2-3-8-16(15)17/h2-9,11-12H,10H2,1H3,(H,20,21) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(isoquinolin-4-yl)-2-(3-methylphenyl)acetamide |
|
| QF0 | Name: | (3S)-3-amino-4-(naphthalen-2-yl)butanoic acid | Formula: | C14 H15 N O2 | SMILES: | O=C(O)CC(N)Cc1ccc2ccccc2c1 | InChi: | InChI=1S/C14H15NO2/c15-13(9-14(16)17)8-10-5-6-11-3-1-2-4-12(11)7-10/h1-7,13H,8-9,15H2,(H,16,17)/t13-/m0/s1 | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-06-14 | Identifier: | (3S)-3-amino-4-(naphthalen-2-yl)butanoic acid |
|
| QF5 | Name: | N-(isoquinolin-4-yl)-2-phenylacetamide | Formula: | C17 H14 N2 O | SMILES: | O=C(Cc1ccccc1)Nc1cncc2ccccc21 | InChi: | InChI=1S/C17H14N2O/c20-17(10-13-6-2-1-3-7-13)19-16-12-18-11-14-8-4-5-9-15(14)16/h1-9,11-12H,10H2,(H,19,20) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(isoquinolin-4-yl)-2-phenylacetamide |
|
| QF6 | Name: | 8-methoxyquinolin-4-amine | Formula: | C10 H10 N2 O | SMILES: | COc1cccc2c(N)ccnc12 | InChi: | InChI=1S/C10H10N2O/c1-13-9-4-2-3-7-8(11)5-6-12-10(7)9/h2-6H,1H3,(H2,11,12) | Definition date: | 2022-06-07 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 8-methoxyquinolin-4-amine |
|
| QF9 | Name: | 2-(3-chloro-5-cyanophenyl)-N-(isoquinolin-4-yl)acetamide | Formula: | C18 H12 Cl N3 O | SMILES: | N#Cc1cc(cc(Cl)c1)CC(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C18H12ClN3O/c19-15-6-12(5-13(7-15)9-20)8-18(23)22-17-11-21-10-14-3-1-2-4-16(14)17/h1-7,10-11H,8H2,(H,22,23) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-cyanophenyl)-N-(isoquinolin-4-yl)acetamide |
|